With an initial investment of over 17 million euros for the development of 5,600 square meters of new laboratories dedicated to pharmaceutical technology and analytical chemistry, Alfasigma confirms its commitment to Research and Development. L’inauguration of ‘Labio 4.0 Marino Golinelli’, this morning in the Pomezia pharmaceutical group plant, is part of a broader corporate strategy of progressive investment in R&D, which allows Alfasigma, one of the top five pharmaceutical companies with Italian capital, to stand out both nationally and internationally for innovation and technological development.
Read Also
- Children grow faster during the school year than during the summer holidays May 30, 2022
- Royal Family in crisis: Elizabeth II furious Aug 12, 2021
- Carlo Conti and the embarrassment of Vanessa Incontrada’s kiss Sep 4, 2021
- Banco Popular signs agreement with Olympic medalist Marileidy Paulino May 20, 2022
- The Bachelorette: The 1st couple photo of Melissa and Leander is here! Dec 10, 2020
- Family asks for support in search of elderly person missing 18 days ago in Valdivia Nov 23, 2022
- Christian Nodal and his unstoppable displays of love for Belinda: a photo, a dinner and a hookah session Sep 20, 2020